KMOV St. Louis on MSN11h
Nasal COVID vaccine developed at WashU approved for clinical trials
The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
Protection from COVID reinfections plummeted from 80% to 5% with omicron
With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...
Medscape4d
FDA Approves Third Tocilizumab Biosimilar
The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...
HUB4d
Convalescent plasma offers a 'blueprint' for future pandemics
Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...
The American Journal of Managed Care6d
FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...
STAT7d
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
Fact-checking RFK Jr.'s claims on vaccines, pesticides at confirmation hearing
Robert F. Kennedy Jr. made claims during his Senate confirmation hearing on issues including vaccines, pesticides and Lyme ...
COVID-19 may attack arteries, increase risk to heart, study finds
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
FDA spars with Waco company over ‘unapproved’ and ‘unlicensed’ human amniotic products
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...